Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sacconi

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Nature Communications|July 21, 2019
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancerPiera Tocci, Roberta Cianfrocca, Valeriana Di Castro, et al.
Cell Death & Disease|March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitorsDomenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.
Cell Death and Differentiation|November 24, 2020
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferationValeria Canu, Sara Donzelli, Andrea Sacconi, et al.
Breast Cancer Research : BCR|June 21, 2018
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophagesSara Donzelli, Elisa Milano, Magdalena Pruszko, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 3, 2018
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot studyFrancesco Marchesi, Giulia Regazzo, Francesca Palombi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2014
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective studyPaola Muti, Andrea Sacconi, Ahmed Hossain, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2024
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal CancerValentina Piastra, Federica Ganci, Andrea Sacconi, et al.
Biomedicines|August 26, 2022
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem CellsIngrid Cifola, Federica Fratini, Beatrice Cardinali, et al.
Aging Cell|October 20, 2023
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitorsAngela Rizzo, Carmen Maresca, Carmen D'Angelo, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Nature Communications|July 21, 2019
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancerPiera Tocci, Roberta Cianfrocca, Valeriana Di Castro, et al.
Cell Death & Disease|March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitorsDomenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.
Cell Death and Differentiation|November 24, 2020
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferationValeria Canu, Sara Donzelli, Andrea Sacconi, et al.
Breast Cancer Research : BCR|June 21, 2018
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophagesSara Donzelli, Elisa Milano, Magdalena Pruszko, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 3, 2018
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot studyFrancesco Marchesi, Giulia Regazzo, Francesca Palombi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2014
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective studyPaola Muti, Andrea Sacconi, Ahmed Hossain, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2024
Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal CancerValentina Piastra, Federica Ganci, Andrea Sacconi, et al.
Biomedicines|August 26, 2022
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem CellsIngrid Cifola, Federica Fratini, Beatrice Cardinali, et al.
Aging Cell|October 20, 2023
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitorsAngela Rizzo, Carmen Maresca, Carmen D'Angelo, et al.
Pageof 12